Ravasio, R., & Ripoli, S. (2023). Cost-minimization analysis of HYQVIA® in the treatment of primary immunodeficiency disease (PID) and secondary immunodeficiency disease (SID) in Italy. AboutOpen, 10(1), 69–77. https://doi.org/10.33393/ao.2023.2584